These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38168007)
1. Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells. Abdulkareem SJ; Jafari-Gharabaghlou D; Farhoudi-Sefidan-Jadid M; Salmani-Javan E; Toroghi F; Zarghami N Daru; 2024 Jun; 32(1):133-144. PubMed ID: 38168007 [TBL] [Abstract][Full Text] [Related]
2. Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells. Shahbazi R; Jafari-Gharabaghlou D; Mirjafary Z; Saeidian H; Zarghami N Pharmacol Rep; 2023 Apr; 75(2):442-455. PubMed ID: 36859742 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Dual Bioactive Compounds Artemisinin and Metformin Co-loaded in PLGA-PEG Nano-particles on Breast Cancer Cell lines: Potential Apoptotic and Anti-proliferative Action. Hassani N; Jafari-Gharabaghlou D; Dadashpour M; Zarghami N Appl Biochem Biotechnol; 2022 Oct; 194(10):4930-4945. PubMed ID: 35674922 [TBL] [Abstract][Full Text] [Related]
4. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells. Salmani-Javan E; Jafari-Gharabaghlou D; Bonabi E; Zarghami N Front Oncol; 2023; 13():1193708. PubMed ID: 37664043 [TBL] [Abstract][Full Text] [Related]
5. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression. Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization, and In-Vitro Evaluation of Silibinin-loaded PEGylated Niosomal Nanoparticles: Potential Anti-Cancer Effects on SW480 Colon Cancer Cells. Alali U; Mohammed Kadhim Al-Tu'ma M; Fadhil Jawad A; Talib Ahmed S; Addai Ali H; Abdulzehra S; Jawad Al-Tu'ma F Asian Pac J Cancer Prev; 2024 Jul; 25(7):2539-2550. PubMed ID: 39068589 [TBL] [Abstract][Full Text] [Related]
7. MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in Mice. Luo D; Wang X; Zhong X; Chang J; He M; Wang H; Li Y; Zhao C; Luo Y; Ran L Anticancer Agents Med Chem; 2022; 22(2):280-293. PubMed ID: 34165412 [TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells. Faramarzi L; Dadashpour M; Sadeghzadeh H; Mahdavi M; Zarghami N Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):737-746. PubMed ID: 30892093 [TBL] [Abstract][Full Text] [Related]
9. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551 [TBL] [Abstract][Full Text] [Related]
10. Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation. Salmani Javan E; Lotfi F; Jafari-Gharabaghlou D; Mousazadeh H; Dadashpour M; Zarghami N Asian Pac J Cancer Prev; 2022 Feb; 23(2):519-527. PubMed ID: 35225464 [TBL] [Abstract][Full Text] [Related]
11. Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells. Firouzi Amandi A; Jokar E; Eslami M; Dadashpour M; Rezaie M; Yazdani Y; Nejati B Med Oncol; 2023 May; 40(6):170. PubMed ID: 37156929 [TBL] [Abstract][Full Text] [Related]
12. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro. Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033 [TBL] [Abstract][Full Text] [Related]
13. Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment. Khoshravan L; Dadashpour M; Hashemi M; Zarghami N Asian Pac J Cancer Prev; 2022 Mar; 23(3):919-927. PubMed ID: 35345364 [TBL] [Abstract][Full Text] [Related]
14. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines. Mohammadinejad S; Jafari-Gharabaghlou D; Zarghami N Asian Pac J Cancer Prev; 2022 Dec; 23(12):4063-4072. PubMed ID: 36579986 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application. Jafari-Gharabaghlou D; Dadashpour M; Khanghah OJ; Salmani-Javan E; Zarghami N Mol Biol Rep; 2023 Apr; 50(4):3023-3033. PubMed ID: 36662452 [TBL] [Abstract][Full Text] [Related]
16. The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells. Sadeghzadeh H; Pilehvar-Soltanahmadi Y; Akbarzadeh A; Dariushnejad H; Sanjarian F; Zarghami N Anticancer Agents Med Chem; 2017; 17(10):1363-1373. PubMed ID: 28270067 [TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of oxaliplatin via folate-decorated niosomal nanoparticles potentiates resistance reversion of colon cancer cells. Abdulzehra S; Jafari-Gharabaghlou D; Zarghami N Heliyon; 2023 Nov; 9(11):e21400. PubMed ID: 37954331 [TBL] [Abstract][Full Text] [Related]
18. Preparation, characterizations and in vitro cytotoxic activity of nickel oxide nanoparticles on HT-29 and SW620 colon cancer cell lines. Khan S; Ansari AA; Malik A; Chaudhary AA; Syed JB; Khan AA J Trace Elem Med Biol; 2019 Mar; 52():12-17. PubMed ID: 30732872 [TBL] [Abstract][Full Text] [Related]
19. Synergistic Anti-proliferative Effects of Metformin and Silibinin Combination on T47D Breast Cancer Cells via hTERT and Cyclin D1 Inhibition. Chatran M; Pilehvar-Soltanahmadi Y; Dadashpour M; Faramarzi L; Rasouli S; Jafari-Gharabaghlou D; Asbaghi N; Zarghami N Drug Res (Stuttg); 2018 Dec; 68(12):710-716. PubMed ID: 29920623 [TBL] [Abstract][Full Text] [Related]
20. Design, optimization, characterization, and Osama H; Sayed OM; Hussein RRS; Abdelrahim M; A Elberry A J Liposome Res; 2020 Jun; 30(2):150-162. PubMed ID: 31039656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]